Loading lesson…
Clinical trials enroll only 3-5% of eligible patients, partly because eligibility screening is time-intensive. AI can assist in matching patients to trials by comparing patient profiles to eligibility criteria — expanding research participation and patient access to cutting-edge treatments.
The US runs over 400,000 registered clinical trials, but fewer than 5% of eligible patients enroll. Screening patients against complex inclusion/exclusion criteria is labor-intensive, and many oncologists and specialists simply don't have time to review the full trial landscape for each patient. AI can match de-identified patient profiles to trial eligibility criteria in seconds — surfacing options that might never have been identified manually.
Historical clinical trial populations have underrepresented women, racial and ethnic minorities, and elderly patients — producing drugs and treatments whose efficacy and safety profiles are less well-characterized in these groups. AI-assisted matching programs that actively flag under-enrollment by demographic subgroup and route eligible patients to trials seeking to address this gap are a tool for both research integrity and health equity.
The big idea: AI screens thousands of trials against a patient profile in seconds. The clinician and research team confirm eligibility and obtain informed consent.
15 questions · take it digitally for instant feedback at tendril.neural-forge.io/learn/quiz/end-healthcare-clinical-trial-matching-adults
What is the core idea behind "Clinical Trial Patient Matching: AI-Assisted Eligibility Screening"?
Which term best describes a foundational idea in "Clinical Trial Patient Matching: AI-Assisted Eligibility Screening"?
A learner studying Clinical Trial Patient Matching: AI-Assisted Eligibility Screening would need to understand which concept?
Which of these is directly relevant to Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
Which of the following is a key point about Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
Which of these does NOT belong in a discussion of Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
What is the key insight about "Trial matching prompt" in the context of Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
What is the key insight about "AI matching is not informed consent" in the context of Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
What is the key insight about "Human review boundary" in the context of Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
Which statement accurately describes an aspect of Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
What does working with Clinical Trial Patient Matching: AI-Assisted Eligibility Screening typically involve?
Which of the following is true about Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
Which best describes the scope of "Clinical Trial Patient Matching: AI-Assisted Eligibility Screening"?
Which section heading best belongs in a lesson about Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?
Which section heading best belongs in a lesson about Clinical Trial Patient Matching: AI-Assisted Eligibility Screening?